Trial Profile
A Prospective Pharmacodynamic Study of Dabigatran Using Peak and Trough Coagulation Test Results in Patients on Therapeutic Doses of Dabigatran
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 May 2012
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics
- 07 May 2012 New trial record